Active-ingredient Dossier
Temozolomide
Active-ingredient Dossier for Temozolomide (alkylating agent). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: APO-TEMOZOLOMIDE
- Brand: TEMIZOLE
- Brand: TEMODAL
- Brand: TEMACCORD
- Brand: APOTEX-Temozolomide
- Brand: Temozolomide Capsules
- Therapeutic area: Oncology
What is Temozolomide Temozolomide is an alkylating agent .
Australian brands containing
Temozolomide — APO-TEMOZOLOMIDE — TEMIZOLE — TEMODAL — TEMACCORD — TEMOZOLOMIDE JUNO
Therapeutic areas
Temozolomide is registered in oncology (7 brands) and complementary medicine (1 brand) .
Sponsor landscape
The ingredient is marketed by seven sponsors: Arrotex Pharmaceuticals, Accord Healthcare, Viatris, Merck Sharp & Dohme, IDT, Juno Pharmaceuticals, and Apotex .
PBS and regulatory activity
Three brands containing temozolomide have PBS-listed items, with the latest PBS schedule date being 1 May 2026 .